Pharmaceutical Product Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
64
About the Report
About the Report
Summary
Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company's service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD's clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, South America, Europe, Middle East, Africa, and Asia-Pacific. PPD is headquartered in Wilmington, North Carolina, the US.
Pharmaceutical Product Development LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 14
Partnerships 15
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
BioDuro Enters into Agreement with Pfizer 16
BioDuro Enters into Agreement with Porton Pharma Solutions 17
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 18
Treos Bio Enters into Agreement with Pharmaceutical Product Development 19
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 22
Pharma Product Development Enters into Agreement with BARDA 23
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24
BioAtla Enters into Co-Development Agreement with BioDuro 25
Boston Strategics Enters into Agreement with Molecular Response 26
Pharmaceutical Product Development and X-Chem Form Joint Venture 27
Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 28
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 29
Debt Offering 30
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 30
Pharmaceutical Product Development Announces Public Offering Of Notes For USD 500 Million 31
Asset Transactions 32
Crown Bioscience Acquires PDX Business Unit from Molecular Response 32
Acquisition 33
LabCorp May Acquire Pharmaceutical Product Development 33
Pharmaceutical Product Development Acquires Evidera 34
BioDuro Acquires Formex 35
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 36
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 37
Pharmaceutical Product Development LLC-Key Competitors 38
Pharmaceutical Product Development LLC-Key Employees 39
Pharmaceutical Product Development LLC-Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 43
Recent Developments 44
Strategy And Business Planning 44
Mar 28, 2018: PPD Expands GMP Biologics Testing Capacity 44
May 18, 2017: PPD Expands Vaccine Development Laboratory 45
Feb 28, 2017: PPD Introduces Rare Disease and Pediatric Center of Excellence 46
Jan 30, 2017: PPD to Open New Clinical Research Unit in Las Vegas 47
Corporate Communications 48
Sep 18, 2018: PPD focused on employee well-being providing uninterrupted client service after Hurricane 48
Jul 24, 2018: PPD Names Ron Garrow as Chief Human Resource Officer 49
May 04, 2018: Christopher Scully Joins PPD as Chief Financial Officer 50
Feb 01, 2018: Pharmaceutical Product Development Appoints Maria Teresa Hilado As Board Director 51
Jan 03, 2018: PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors 52
Government and Public Interest 53
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 53
Feb 21, 2018: PPD Recognized for Superior Employee Development 55
Mar 02, 2017: PPD Awarded National Institutes of Health Contract for HIV Research Support 56
Product News 57
Jun 25, 2018: PPD's PatientAdvantage Inverts Traditional Clinical Trial Delivery Method 57
Other Significant Developments 58
Jul 25, 2018: PPD Expands Central Labs' Preclarus technology, helping clients accelerate and enhance clinical research decision making 58
Apr 23, 2018: Acurian and Synexus Launch NASH Patient Enrollment Solution 59
Feb 28, 2018: PPD and Acurian Introduce Innovative Patient Concierge Service for Clinical Trials 60
Oct 24, 2017: Evidera Expands Patient-Centered Research Services 61
May 08, 2017: PPD Creates Dedicated Real-world Research and Market Access Unit by Combining Medical Affairs Research Operations and Evidera 62
Mar 23, 2017: PPD Announces Industry-First Apprenticeship for Clinical Research Associates 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
List of Figure
List of Figures
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11
List of Table
List of Tables
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharmaceutical Product Development LLC, Deals By Therapy Area, 2012 to YTD 2018 9
Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11
Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 14
Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
BioDuro Enters into Agreement with Pfizer 16
BioDuro Enters into Agreement with Porton Pharma Solutions 17
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 18
Treos Bio Enters into Agreement with Pharmaceutical Product Development 19
Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20
Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21
Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 22
Pharma Product Development Enters into Agreement with BARDA 23
Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24
BioAtla Enters into Co-Development Agreement with BioDuro 25
Boston Strategics Enters into Agreement with Molecular Response 26
Pharmaceutical Product Development and X-Chem Form Joint Venture 27
Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 28
Pharma Product Development Expands Co-Development Agreement With VirtualScopics 29
Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 30
Pharmaceutical Product Development Announces Public Offering Of Notes For USD 500 Million 31
Crown Bioscience Acquires PDX Business Unit from Molecular Response 32
LabCorp May Acquire Pharmaceutical Product Development 33
Pharmaceutical Product Development Acquires Evidera 34
BioDuro Acquires Formex 35
Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 36
Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 37
Pharmaceutical Product Development LLC, Key Competitors 38
Pharmaceutical Product Development LLC, Key Employees 39
Pharmaceutical Product Development LLC, Other Locations 40
Pharmaceutical Product Development LLC, Subsidiaries 42
Pharmaceutical Product Development LLC, Joint Venture 43
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.